• Economy
  • Politics
  • Society
  • Securities
  • Real estate
  • Culture
  • Entertainment
  • Sports
  • Opinion
Economy Corporation Pharma & Bio
Society Politics IT·Science
Securities Real Estate Global
Opinion Entertainment Sports Culture
Video Auto in Golf in
PHARM EDAILY Market in TheBeLT
IT·Science
Technology

"After Oral Drugs, Next Up Are Indications"... A Look at Novo and Lilly's Next-Generation Pipelines

As the first round of the “weight-loss drug war” between Eli Lilly and Novo Nordisk effectively tilts in Lilly’s favor, the two pharmaceutical giants have entered a high-stakes second round, competing…
  • 2026-08-17 07:07:03
  • Kim Seung-kwon
Mobile

Fan Cam, Multi-Window, Mirror View… Samsung’s Foldable Phone ‘3M Features’ Draw Attention

SamsungElectronics(005930)has set out to target young users by highlighting the camera and multitasking features enabled by the foldable form factor of the Galaxy Z Fold8 Ultra, Fold8, and Flip8.Accor…
  • 2026-08-16 06:00:04
  • Shin Yeong-bin
Technology

JWPHARMACEUTICAL Sees Dual Boost from Earnings and New Gout Drug… SAMSUNG BIOLOGICS Labor and Management Agree to Post-Negotiation Adjustments [Weekly Biotech Roundup]

(Graphic: Generative AI) During the second week of August (August 10–14), JWPHARMACEUTICAL(001060)in the pharmaceutical and biotech sector drew attention by successively announcing strong first-ha…
  • 2026-08-15 08:31:01
  • Minji Son
Technology

DRTech, TissueGene, and Finemedix All Rally [K-bio Pulse]

On the 13th, three companies in Korea’s pharmaceutical, biotech, and healthcare sectors—#DRTech, #KolonTissueGene, and #FinemediX—all posted gains. DR Tech and FinemediX rose on the back of improved e…
  • 2026-08-15 08:04:03
  • Kim Seung-kwon
Technology

[Bio Spotlight] DRTECH Corporation Soars to Daily Limit Up… Kolon TissueGene, Inc. Also Rebounds Slightly

On the 13th, in the domestic pharmaceutical, biotech, and healthcare sectors, DRTECH Corporation(214680) Kolon TissueGene, Inc.(950160) #Finemedix Co., Ltd. all posted gains. DRTECH Corporation and Fi…
  • 2026-08-15 08:04:02
  • Kim Seung-kwon
Technology

JWPHARMACEUTICAL Files IND Application for Phase 3 Domestic Clinical Trials of 'Once-Every-Two-Weeks' Weight-Loss Drug

JWPHARMACEUTICAL CI (Photo courtesy of JWPHARMACEUTICAL) JWPHARMACEUTICAL(001060)announced on the 14th that it has submitted an Investigational New Drug (IND) application to the Ministry of Food a…
  • 2026-08-14 22:35:03
  • KIM SAE-MI
Internet

Amid 'Chipflation'… Samsung MX's External Memory Purchases Also Rose 211% in the First Half

(Photo: SamsungElectronics) SamsungElectronics(005930)’s MX Business Division has taken a defensive stance by boosting its global smartphone market share despite facing significant cost pressures …
  • 2026-08-14 18:22:55
  • Han Kwangbeom
Internet

Kweather Co., Ltd. Reports First-Half Revenue of 9.35 Billion Won… Up 7.9% Year-Over-Year

Kweather Co., Ltd.(068100)announced on the 14th that its consolidated net income for the first half of this year was 320 million won, a 124.4% increase compared to the same period last year.Revenue fo…
  • 2026-08-14 18:21:06
  • Shin Yeong-bin
Internet

CLOBOT Co., Ltd Reports First-Half Revenue of 17 Billion Won… Up 32.9% Year-Over-Year

#CLOBOT Co., Ltd announced on the 14th that its consolidated operating loss for the first half of this year was 5.34 billion won, a level similar to the 5.26 billion won recorded in the same period la…
  • 2026-08-14 18:18:18
  • Shin Yeong-bin
Internet

LG Corp. and NVIDIA to Unveil Humanoid Robot in Q1 Next Year… Also to Build 80MW AI Factory

LG Corp. ( LG Corp.(003550)) is partnering with NVIDIA to develop next-generation humanoid robots. The company will leverage NVIDIA’s robotics computing platform and humanoid artificial intelligence (…
  • 2026-08-14 17:55:20
  • Kim Hyun-ah
1 2 3 4 5 6 7 8 9 10 next

PHARM EDAILY

Shorts

EDAILY
  • 92, Tongil-ro, Jung-gu, Seoul, Korea
  • +82 2 3772 0114
  • webmaster@edaily.co.kr

※ This article has been translated using AI technology for the convenience of readers.

EDAILY provides this translation on an “as is” basis and makes no warranties, express or implied, regarding its accuracy, reliability, completeness, merchantability, or fitness for a particular purpose.
Due to the limitations of machine translation, the translated content may differ from the original Korean article. In the event of any discrepancy, the original Korean version shall prevail.
EDAILY shall not be liable for any loss or damage arising from the use of, or reliance on, the translated content.

© 2026 Copyrights by edaily. All Rights Reserved.
Korea
English